Revive Rx LLC dba Revive Rx Pharmacy

Form 483 issued February 7, 2025 · Houston, Texas

Inspection
Jan 27 – Feb 7, 2025
Investigator
Jazmine N. Brown
Observations
7
Pages
7
FEI number
3016710945

In short: On February 7, 2025, FDA issued a Form 483 with 7 observations to Revive Rx LLC dba Revive Rx Pharmacy in Houston, Texas (FEI 3016710945) after an inspection that ran Jan 27 – Feb 7, 2025. The investigator was Jazmine N. Brown.

What FDA observed

Preview: the opening words of each observation
  1. 01
    FDCA 501(a)(2)(A)

    Sterile clings and Materials were exposed to lower than…

  2. 02
    FDCA 501(a)(2)(A)

    Microbial contamination was present in the ISO 5 area and areas…

  3. 03
    FDCA 501(a)(2)(A)

    Lack of and Inadequate routine environmental monitoring in the ISO 5…

  4. 04
    FDCA 501(a)(2)(A)

    Failure to conduct media fills that closely simulate aseptic production operations under the worst-case…

3 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Revive Rx LLC dba Revive Rx Pharmacy?

FDA listed 7 observations on this Form 483. The opening words of each observation are shown on this page.

Who inspected Revive Rx LLC dba Revive Rx Pharmacy?

Jazmine N. Brown is named on this Form 483, for the inspection of Jan 27 – Feb 7, 2025. Each investigator has a profile showing what they cite most.

When was Revive Rx LLC dba Revive Rx Pharmacy inspected by FDA?

The inspection ran Jan 27 – Feb 7, 2025, and the Form 483 is dated February 7, 2025.

How do I get the full Form 483 for Revive Rx LLC dba Revive Rx Pharmacy?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free